Improving the generalizability of protein-ligand binding predictions with AI-Bind

Developing accurate and robust predictors for protein-ligand interactions remains extremely challenging in early-stage drug discovery, especially for previously unseen targets and drug molecules. Existing machine learning models often fail to generalize, relying on topological shortcuts. AI-Bind maximizes inductive test performance by combining network-based negative sampling with unsupervised pre-training for molecular embeddings. This provides interpretable predictions, actively identifies binding sites, and greatly accelerates the computational biology pipeline.